References
- Arundel C.A., Vines C.M., Tofilon P.J. Chromatin modifications associated with N-methylamide-induced radiosensitization of clone A cells. Cancer Research 1988; 48: 5669–5673
- Berry R.J., Asquith J.C. Cell cycle dependent and hypoxic radiosensitizers. Advances in Chemical Radiosensitization. Vienna IAEA. 1973; 52–58
- Boothman D.A., Trask D.K., Pardee A.B. Inhibition of potentially lethal DNA damage rapair in human tumor cells by beta-lapachone, an activator of topoisomerase I. Cancer Research 1989; 49: 605–612
- Crespi M.D., Mladovan A.G., Baldi A. Increment of DNA topoisomerases in chemically and virally transformed cells. Exp. Cell Res 1988; 175: 206–215
- Doggett R.L.S., Bagshaw M.A., Kaplan H.S. Combined therapy using chemotherapeutic agents and radiotherapy. Modern trends in Radiotherapy. Butterworths, London 1967; 107–131, In
- Heck M.M., Hittleman W.N., Earnshaw W.C. Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proceedings of the National Academy of Science, USA 1988; 85: 1086–1090
- Hsiang Y-H., Hertzberg R., Hecht S., Liu L.F. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. Journal of Biological Chemistry 1985; 260: 14873–14878
- Hsiang Y-H., Lihou M.G., Lui L.F. Arrest of replication forks by drug stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Research 1989; 49: 5077–5082
- Ivanov V.A. Variations in DNA topoisomerase I activity after gamma irradiation of mature neurons. Neuroscience Letters 1988; 94: 99–103
- Johnstone A., McNerney R. Changes in topoisomerase I activity after irradiation of lymphoid cells. Bioscience Reports 1985; 5: 907–912
- Lehmann A.R., Arlett C.F., Burke J.F., Green M.H.L., James M.R., Lowe J.E. A derivative of an ataxia-telangiectasia (A-T) cell line with normal radiosensitivity but A-T-like inhibition of DNA synthesis. International Journal of Radiation Biology 1986; 49: 639–643
- Liu L.F. DNA topoisomerase poisons as antitumour drugs. Annual Review of Biochemistry 1989; 58: 351–375
- Musk S.R.R., Steel G.G. The inhibition of cellular recovery in human tumour cells by inhibitors of topoisomerase. British Journal of Cancer 1990; 62: 364–367
- Potmesil M., Giovanella B.C., Stehlin J.S., Wall M.E., Wani M.C., Lui L.F., Silber R. Preclinical development of 9-amino and 10,11-methylendioxy camptothecin. Third conference on DNA topoisomerases in therapy 1990; 33–33, (abstract)
- Rose K.M., Szopa J., Han F.S., Cheng Y.C., Richter A., Scheer U. Association of DNA topoisomerase I and RNA polymerase I: a possible role for topoisomerase I in ribosomal gene transcription. Chromosoma 1988; 96: 411–416
- Smith P.J., Anderson C.O., Watson J.V. Abnormal retention of X-irradiated ataxiatelangiectasia fibroblasts in G2 phase of the cell cycle: cellular RNA content, chromatin stability and the effects of 3-aminobenzamide. International Journal of Radiation Biology 1985a; 47: 701–712
- Smith P.J., Anderson C.O., Watson J.V. Effects of X-irradiation and sodium butyrate on cellcycle traverse of normal and radiosensitive lymphoblastoid cells. Experimental Cell Research 1985b; 160: 331–342
- Smith P.J., Makinson T.A. Cellular consequences of overproduction of DNA topoisomerase II in an ataxia-telangiectasia cell line. Cancer Research 1989; 49: 1118–1124
- Smith P.J., Makinson T.A., Watson J.V. Enhanced sensitivity to camptothecin in ataxiatelangiectasia cells and its relationship with the expression of DNA topoisomerase I. International Journal of Radiation Biology 1989; 55: 217–231
- Wang J.C. DNA topoisomerases. Annual Review of Biochemistry 1985; 54: 665–697
- Warters R.L., Lyons B.W., Kennedy K., Li T.M. Topoisomerase activity in irradiated mammalian cells. Mutation Research, 216: 43–55
- Watson J.V., Chambers S.H., Smith P.J. A pragmatic approach to analysis of DNA histograms with a definable G1 peak. Cytometry 1987; 8: 1–8
- Watson J.V. A linear transform of the multi-target survival curve. British Journal of Radiology 1978; 51: 534–538
- Yarnold J.R., Horwich A., Duchesne G., Westbrook K., Gibbs J.E., Peckham M.J. Chemotherapy and radiotherapy for advanced testicular non-seminoma 1. The influence of sequence and timing of drugs and radiation on the appearance of normal tissue damage. Radiotherapy and Oncology 1983; 1: 91–99
- Zhang H., Wang J.C., Liu L.F. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Proceedings of the National Academy of Science, USA 1988; 85: 1060–1064